Paid Clinical Trials in Tucson, AZ

As of July 2026, 466 paid clinical trials are recruiting in Tucson, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Tucson offers studies at sites including University of Arizona for conditions such as Breast Cancer, Obesity, Overweight, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Trials by specialty in Tucson

Oncology· 155 Blood cancer· 44 Cardiology· 35 Women's health· 30 Heart disease· 27 Endocrinology· 27 Breast oncology· 25 Metabolic health· 22 Lung disease· 21 Weight loss· 20 Lung oncology· 18 Autoimmune disease· 18

Trials by drug in Tucson

Dexamethasone· 8 Methotrexate· 5 Anastrozole· 4 Letrozole· 4 Prednisone· 4 Folinic acid· 3 Prednisolone· 3 Tamoxifen· 3 Allopurinol· 2 Apixaban· 2 Mammography· 2 Orforglipron· 2 Palbociclib· 2 SoC· 2 Ablation· 1

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Tucson

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Apixaban Versus Warfarin for Left Ventricular Thrombus

for Left Ventricular Thrombus

1 location in Tucson

Sponsor: University of Arizona

Sex: All·Age: 18+

Code: NCT07709780·Phase 3·Recruiting·Listed Jul 17, 2026

Apply to this trial

Breathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in Pregnancy

for Hypertension Disorders in Pregnancy

1 location in Tucson

Sponsor: University of Arizona

Sex: Female·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07687745·EARLY_Phase 1·Recruiting·Listed Jul 7, 2026

Apply to this trial

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

for Epiretinal Membrane

Sites in Tucson +4 more locations

Sponsor: Carl Zeiss Meditec-Dublin CoCe

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07680244·Recruiting·Listed Jul 2, 2026

Apply to this trial

A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors

for Obesity and Cardiovascular Risk

Sites in Tucson, Chandler +10 more locations

Sponsor: BioAge Labs, Inc.

Sex: All·Age: 18+

Code: NCT07656727·Phase 2·Recruiting·Listed Jun 18, 2026

Apply to this trial

416 clinical trials

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

for Overweight

Sites in Tucson, Chandler +53 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07575932·Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

for Overweight

Drug: Eloralintide

Sites in Tucson, Chandler +38 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07589608·Phase 2·Recruiting·Listed May 2026

Apply to this trial

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for Cardiovascular Disease and Lipoprotein(a)

Drug: Pelacarsen

Sites in Tucson, Gilbert +110 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for Solid Tumors

Drug: INCB161734

Sites in Tucson, Chandler +66 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07522073·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

for MASH - Metabolic Dysfunction-Associated Steatohepatitis

Sites in Tucson, Chandler +29 more locations

Sponsor: Rivus Pharmaceuticals, Inc.

Sex: All·Age: 30+

Code: NCT07491458·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

for Post Traumatic Stress Disorder

Drug: TSND-201

Sites in Tucson +31 more locations

Sponsor: Transcend Therapeutics

Sex: All·Age: 18+

Code: NCT07456696·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for Primary Sjogren's Disease

Drug: Telitacicept

Sites in Tucson, Chandler +26 more locations

Sponsor: Vor Biopharma

Sex: All·Age: 18 - 75

Code: NCT07404865·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for Overweight

Drug: Eloralintide

Sites in Tucson, Scottsdale +57 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07392190·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

for Chronic Idiopathic Constipation (CIC)

Drug: Tenapanor

Sites in Tucson, Chandler +107 more locations

Sponsor: Ardelyx

Sex: All·Age: 18 - 80

Code: NCT07382167·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for Pancreatic Cancer

Sites in Tucson +38 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for Osteoarthritis

Drug: Eloralintide

Sites in Tucson, Mesa +36 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07353931·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

for Obesity or Overweight

Drug: Enicepatide

Sites in Tucson +35 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07351045·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for Obesity or Overweight

Drug: Enicepatide

Sites in Tucson +34 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07351058·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

for Parkinson's Disease

Sites in Tucson, Phoenix +24 more locations

Sponsor: Bayer

Sex: All·Age: 45 - 75

Code: NCT07330258·Recruiting·Listed Jan 2026

Apply to this trial

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

for Metabolic Dysfunction-associated Steatohepatitis

Sites in Tucson, Chandler +60 more locations

Sponsor: Eccogene

Sex: All·Age: 18 - 75

Code: NCT07288138·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for Type 2 Diabetes

Sites in Tucson, Chandler +58 more locations

Sponsor: Sparrow Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07296484·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for Overweight

Drug: Eloralintide

Sites in Tucson +59 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for CRC (Colorectal Cancer)

Drug: Bevacizumab

Sites in Tucson +69 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for Squamous Cell Carcinoma of Head and Neck

Drug: Amivantamab

Sites in Tucson, Chandler +43 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

for Severe Hypertriglyceridemia

Drug: Solbinsiran

Sites in Tucson, Phoenix +27 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07269210·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for Untreated, Unresectable, or Metastatic Colorectal Cancer

Drug: Bevacizumab

Sites in Tucson +44 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07221357·Phase 2, Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

for Peripheral Arterial Disease

Drug: Orforglipron

Sites in Tucson, Gilbert +30 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07223593·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for Carcinoma, Transitional Cell

Sites in Tucson +61 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for Metabolic Dysfunction-Associated Steatotic Liver Disease

Sites in Tucson, Gilbert +139 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for Breast Neoplasms

Sites in Tucson, Chandler +116 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

for Elevated Lp(a)

Drug: Muvalaplin

Sites in Tucson, Apache Junction +128 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for Ovarian Cancer

Drug: INCB123667

Sites in Tucson +46 more locations

Sponsor: Incyte Corporation

Sex: Female·Age: 18+

Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Duvakitug

Sites in Tucson, Scottsdale +92 more locations

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for Cardiovascular Disease

Drug: Olpasiran

Sites in Tucson, Scottsdale +199 more locations

Sponsor: Amgen

Sex: All·Age: 50 - 105

Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

for Obesity

Drug: Eloralintide

Sites in Tucson, Gilbert +24 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07215559·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for Diabetes Mellitus, Type 2

Drug: Empagliflozin

Sites in Tucson, Chandler +204 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07064473·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

for Pulmonary Arterial Hypertension

Sites in Tucson, Scottsdale +13 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07218029·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for Healthy

Sites in Tucson, Phoenix +120 more locations

Sponsor: Pfizer

Sex: All·Age: 1 Day - 49·Accepts healthy volunteers

Code: NCT07160244·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for Gout

Drug: Dotinurad

Sites in Tucson, Gilbert +68 more locations

Sponsor: Crystalys Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07089875·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for Tophaceous Gout

Drug: Dotinurad

Sites in Tucson, Gilbert +75 more locations

Sponsor: Crystalys Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07089888·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis

Drug: Duvakitug

Sites in Tucson +27 more locations

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07185009·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for Secondary Progressive Multiple Sclerosis (SPMS)

Drug: Remibrutinib

Sites in Tucson, Phoenix +33 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT07225504·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

for Radiographic Axial Spondyloarthritis

Drug: Tulisokibart

Sites in Tucson, Gilbert +32 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18 - 80

Code: NCT07133633·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for Metabolic Dysfunction Associated Steatohepatitis (MASH)

Drug: Survodutide

Sites in Tucson, Scottsdale +161 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

Sites in Tucson, Gilbert +167 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Top Research Study Locations in Tucson

Researchers run research studies in Tucson, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
University of Arizona	Amblyopia, Aging, Breast Cancer	82
Banner University Medical Center - Tucson	Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm	50
University of Arizona Cancer Center-North Campus	Acute Myeloid Leukemia, Stage IVB Prostate Cancer AJCC v8, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm	34
University of Arizona Cancer Center	Advanced Solid Tumor, Breast Cancer, Mantle Cell Lymphoma	25
The University of Arizona Cancer Center	Advanced Solid Tumor, Breast Cancer, Unresectable Solid Tumor	12
Del Sol Research Management, LLC	Chronic Idiopathic Constipation (CIC), Contraception, Liver Fibrosis	10
Pima Heart and Vascular	Atrial Fibrillation, Heart Failure, Deep Venous Thrombosis	9
Center for Neurosciences	Focal Epilepsy, Epilepsy, Glioblastoma (GBM)	7
GSK Investigational Site	Non-alcoholic Fatty Liver Disease, Chickenpox, Colonic Neoplasms	7
The University of Arizona Cancer Center - North Campus	Neoplasm Metastasis, Carcinoma, Non-Small-Cell Lung, Acute Myeloid Leukemia Refractory	7
Banner University Medical Center	Arteriovenous Fistula, Atrial Fibrillation, Blood Pressure Measurement in Pregnancy	6
Tucson Medical Center	Mitral Regurgitation, Tricuspid Regurgitation, Aortic Stenosis	6
University of Arizona Cancer Center-Orange Grove Campus	Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8	6
Arizona Liver Health - Tucson	Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis	5
Noble Clinical Research	Bipolar Depression, Bipolar Disorder, Bipolar I Disorder	5
Del Sol Research Management	Major Depressive Disorder, Lower Urinary Tract Symptoms (LUTS), Overweight or Obesity and Elevated Liver Fat	4
Pima Heart & Vascular	Atrial Fibrillation, Coronary Artery Disease, High-Risk Percutaneous Coronary Intervention	4
The University of Arizona	Breathing Exercises, Breathing Techniques, CAR T-Cell Therapy	4
Tucson Cystic Fibrosis Center	Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation	4
University of Arizona Cancer Center - Prevention Research Clinic	Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Atypical Ductal Hyperplasia	4
Adobe Clinical Research, LLC	Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH)	3
Arizona Cancer Center at UMC North/University Medical Center	Bladder Cancer, Brain Metastases, Cancer Survivors	3
Arizona Clinical Trials	Obesity or Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2	3
Eclipse Clinical Research	Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Healthy	3
Southern Arizona VA Health Care System	Diabetic Foot Ulcer, End Stage Kidney Disease, Non-small Cell Lung Cancer	3

Active & Upcoming Studies in Tucson (2026)

Recruiting trials in Tucson grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Vaccines (2 active studies)

HIV / STI (1 active study)

Wellness Intervention for Smoking and HIV · University of Arizona

Pediatric (1 active study)

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.

Common conditions studied in Tucson

Breast Cancer (11 active studies)
Obesity (10 active studies)
Overweight (9 active studies)
Acute Myeloid Leukemia (8 active studies)
Atrial Fibrillation (6 active studies)
Cardiovascular Diseases (6 active studies)

Leading research sponsors in Tucson

University of Arizona
AstraZeneca
Eli Lilly and Company
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC

Frequently asked questions

How many paid clinical trials are currently recruiting in Tucson?

There are approximately 466 recruiting clinical trials in Tucson, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Tucson pay participants?

Most recruiting trials in Tucson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Tucson?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Tucson?

The most common conditions under active study in Tucson include Breast Cancer (11), Obesity (10), Overweight (9), Acute Myeloid Leukemia (8), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Tucson?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tucson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Tucson?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Tucson?

Recruiting research sites in Tucson include University of Arizona, Banner University Medical Center - Tucson, University of Arizona Cancer Center-North Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Tucson right now?

The largest active categories in Tucson are Cancer & tumors (153), Diabetes & metabolic (34), Cardiovascular (34). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Related healthcare resources in Arizona

Latest Arizona clinical trials research report

Trials by condition in Tucson

Breast Cancer· 11 Obesity· 10 Acute Myeloid Leukemia· 8 Atrial Fibrillation· 6

Paid Clinical Trials in Tucson, AZ

Trials by specialty in Tucson

Trials by drug in Tucson

Newly added in Tucson

416 clinical trials

Top Research Study Locations in Tucson

Active & Upcoming Studies in Tucson (2026)

Cancer & tumors (153 active studies)

Diabetes & metabolic (34 active studies)

Cardiovascular (34 active studies)

Neurology & pain (29 active studies)

Mental health & behavior (10 active studies)

Eye & vision (4 active studies)

Vaccines (2 active studies)

HIV / STI (1 active study)

Pediatric (1 active study)

Common conditions studied in Tucson

Leading research sponsors in Tucson

Frequently asked questions

How many paid clinical trials are currently recruiting in Tucson?

Do clinical trials in Tucson pay participants?

Who can participate in a clinical trial in Tucson?

What conditions are most commonly studied in Tucson?

Are there clinical trials for healthy volunteers in Tucson?

How do I enroll in a clinical trial in Tucson?

Where can I take part in paid clinical trials in Tucson?

What kinds of studies are recruiting in Tucson right now?

Browse more clinical trials

Other cities in Arizona

Related healthcare resources in Arizona

Trials by condition in Tucson